[1]
“Evaluation Of In-vitro Efficacy Of Betalactam/Non Betalactam Antimicrobials Against ESBL Genotypes from Wound Infection”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 3, pp. 302–307, May 2024, doi: 10.25004/IJPSDR.2024.160301.